The combination of glucocorticoids with steroid-sparing immunosuppressants is effective in the management of immunoglobulin G4-related disease (#IgG4RD) associated with coronary involvement. Study in @journalofcmr.bsky.social @scmrorg.bsky.social
Read here: https://bit.ly/45lwTPe
Read here: https://bit.ly/45lwTPe
Medication Combination Effective for IgG4-RD With Coronary Involvement
IgG4-RD with vascular involvement is not uncommon and can lead to serious complications such as ischemic heart disease or aneurysm rupture.
bit.ly
January 21, 2026 at 5:54 PM
The combination of glucocorticoids with steroid-sparing immunosuppressants is effective in the management of immunoglobulin G4-related disease (#IgG4RD) associated with coronary involvement. Study in @journalofcmr.bsky.social @scmrorg.bsky.social
Read here: https://bit.ly/45lwTPe
Read here: https://bit.ly/45lwTPe
#Ultrasonography features in immunoglobulin G4-related disease (#IgG4RD)-associated #KidneyDisease (IgG4-RKD) show characteristic findings that correlate with serological disease and the extent of kidney dysfunction. Study in Frontiers in Medicine
Read more: https://bit.ly/3Z0Oqsg
Read more: https://bit.ly/3Z0Oqsg
Ultrasonography Useful in Diagnosing, Tracking Progression of IgG4-RKD
Recent research showed that combinations of ultrasonographic features were useful to identify and track patients with IgG4-RD-related kidney disease.
bit.ly
January 6, 2026 at 4:08 PM
#Ultrasonography features in immunoglobulin G4-related disease (#IgG4RD)-associated #KidneyDisease (IgG4-RKD) show characteristic findings that correlate with serological disease and the extent of kidney dysfunction. Study in Frontiers in Medicine
Read more: https://bit.ly/3Z0Oqsg
Read more: https://bit.ly/3Z0Oqsg
IgG4 not done.No clinical manifestations to suggest IgG4RD
December 22, 2025 at 9:31 PM
IgG4 not done.No clinical manifestations to suggest IgG4RD
I don’t think it was ordered here, was it @alishueib.bsky.social ? What would be the rationale? No IgG4RD flavor here that I can see…
December 22, 2025 at 8:05 PM
I don’t think it was ordered here, was it @alishueib.bsky.social ? What would be the rationale? No IgG4RD flavor here that I can see…
A patient with #Colitis associated with immunoglobulin G4-related disease (#IgG4RD) was successfully managed with #Steroids and #Rituximab. Case report in @annalsofim.bsky.social Clinical Cases
Read more: https://bit.ly/3Kpw4hd
#RareDisease #MedTwitter #InternalMedicine
Read more: https://bit.ly/3Kpw4hd
#RareDisease #MedTwitter #InternalMedicine
Case Report: IgG4-Related Colitis Managed With Steroids and Rituximab
A 34-year-old male patient with IgG4-related colitis was successfully managed with steroids and rituximab, without the need for colectomy.
www.rarediseaseadvisor.com
December 15, 2025 at 4:08 PM
A patient with #Colitis associated with immunoglobulin G4-related disease (#IgG4RD) was successfully managed with #Steroids and #Rituximab. Case report in @annalsofim.bsky.social Clinical Cases
Read more: https://bit.ly/3Kpw4hd
#RareDisease #MedTwitter #InternalMedicine
Read more: https://bit.ly/3Kpw4hd
#RareDisease #MedTwitter #InternalMedicine
The American College of Rheumatology awarded its 2025 Presidential Gold Medal to Dr. Eric Matteson for his achievements and service, working with challenging #AutoimmuneDiseases, from #ANCA-associated vasculitis and #Scleroderma to #PolyarteritisNodosa and #IgG4RD
Read here: https://bit.ly/3KVgf1O
Read here: https://bit.ly/3KVgf1O
Presidential Medal Follows Lifetime of Work in Rheumatology's Complex Diseases
The American College of Rheumatology awarded its 2025 Presidential Gold Medal to Dr. Eric Matteson for his achievements and service.
bit.ly
December 11, 2025 at 7:25 PM
The American College of Rheumatology awarded its 2025 Presidential Gold Medal to Dr. Eric Matteson for his achievements and service, working with challenging #AutoimmuneDiseases, from #ANCA-associated vasculitis and #Scleroderma to #PolyarteritisNodosa and #IgG4RD
Read here: https://bit.ly/3KVgf1O
Read here: https://bit.ly/3KVgf1O
A female patient in her 40s was diagnosed with coexisting synovitis, acne, pustulosis, hyperostosis, and osteitis (#SAPHO) syndrome and immunoglobulin G4-related disease (#IgG4RD). Case report published in Clinical & Translational Immunology.
Read here: https://bit.ly/4pUB6RX
#RareDisease #MedSky
Read here: https://bit.ly/4pUB6RX
#RareDisease #MedSky
Case Report: Concurrent SAPHO Syndrome and IgG4-RD
A middle-aged female patient was concurrently diagnosed with SAPHO syndrome and IgG4-RD and successfully treated with upadacitinib and prednisone.
bit.ly
December 8, 2025 at 4:47 PM
A female patient in her 40s was diagnosed with coexisting synovitis, acne, pustulosis, hyperostosis, and osteitis (#SAPHO) syndrome and immunoglobulin G4-related disease (#IgG4RD). Case report published in Clinical & Translational Immunology.
Read here: https://bit.ly/4pUB6RX
#RareDisease #MedSky
Read here: https://bit.ly/4pUB6RX
#RareDisease #MedSky
Chinese researchers have identified overlapping but distinct clinicopathologic features of immunoglobulin 4-related ophthalmic disease (#IgG4ROD), a form of IgG4-related disease (#IgG4RD), and #CastlemanDisease (CD). Report in the Indian Journal of Ophthalmology
Read more: https://bit.ly/48NGDDX
Read more: https://bit.ly/48NGDDX
Differences Observed in Clinical Features of IgG4-ROD and Castleman Disease
Both IgG4-ROD and Castleman disease may present as orbital masses or lacrimal gland enlargement, but they differ in imaging and histologic markers.
bit.ly
December 4, 2025 at 5:50 PM
Chinese researchers have identified overlapping but distinct clinicopathologic features of immunoglobulin 4-related ophthalmic disease (#IgG4ROD), a form of IgG4-related disease (#IgG4RD), and #CastlemanDisease (CD). Report in the Indian Journal of Ophthalmology
Read more: https://bit.ly/48NGDDX
Read more: https://bit.ly/48NGDDX
Researchers developed a #MachineLearning model that can be used to differentiate between immunoglobulin G4-related disease (#IgG4RD) associated with #Sialadenitis and primary Sjögren’s syndrome (#pSS). Study in International Dental Journal.
Read more: https://bit.ly/3XTW4UI
#RareDisease #MedSky
Read more: https://bit.ly/3XTW4UI
#RareDisease #MedSky
ML Model Differentiates Between IgG4-Related Sialadenitis, Primary Sjögren's Syndrome
Researchers developed a machine learning model to help differentiate between IgG4-related sialadenitis and primary Sjögren's syndrome.
bit.ly
November 27, 2025 at 5:13 PM
Researchers developed a #MachineLearning model that can be used to differentiate between immunoglobulin G4-related disease (#IgG4RD) associated with #Sialadenitis and primary Sjögren’s syndrome (#pSS). Study in International Dental Journal.
Read more: https://bit.ly/3XTW4UI
#RareDisease #MedSky
Read more: https://bit.ly/3XTW4UI
#RareDisease #MedSky
Immunoglobulin G4-related disease (#IgG4RD) is associated with distinct allergen-specific IgE and IgG4 signatures, with certain environmental antigens linked to organ-specific involvement. Study in @allergy-eaaci.bsky.social
Read here: https://bit.ly/43SpXbH
#RareDisease #MedSky
Read here: https://bit.ly/43SpXbH
#RareDisease #MedSky
Distinct Allergen-Specific IgE, IgG4 Signatures Define Organ Involvement in IgG4-RD
New research showed that IgG4-RD features distinct allergen-specific IgE and IgG4 signatures, with some environmental antigens tied to organ involvement.
bit.ly
November 25, 2025 at 6:53 PM
Immunoglobulin G4-related disease (#IgG4RD) is associated with distinct allergen-specific IgE and IgG4 signatures, with certain environmental antigens linked to organ-specific involvement. Study in @allergy-eaaci.bsky.social
Read here: https://bit.ly/43SpXbH
#RareDisease #MedSky
Read here: https://bit.ly/43SpXbH
#RareDisease #MedSky
Mahsa Pazokifard shares her powerful story of spending years searching for answers before finally being diagnosed with IgG4-Related Disease — and how self-advocacy became her lifeline.
Listen to the full episode: ghlf.org/the-health-a...
#RareDisease #IgG4RD #PatientAdvocacy
Listen to the full episode: ghlf.org/the-health-a...
#RareDisease #IgG4RD #PatientAdvocacy
November 23, 2025 at 9:49 PM
Mahsa Pazokifard shares her powerful story of spending years searching for answers before finally being diagnosed with IgG4-Related Disease — and how self-advocacy became her lifeline.
Listen to the full episode: ghlf.org/the-health-a...
#RareDisease #IgG4RD #PatientAdvocacy
Listen to the full episode: ghlf.org/the-health-a...
#RareDisease #IgG4RD #PatientAdvocacy
Investigators have found that baseline T-cell activation patterns may predict which patients with immunoglobulin G4-related disease (#IgG4RD) are more likely to respond to #Abatacept, according to a letter to the editor in the European Journal of Internal Medicine.
Read more: https://bit.ly/3Me1kzY
Read more: https://bit.ly/3Me1kzY
Peripheral T Lymphocyte Activation State May Predict Abatacept Response in IgG4-RD
New research showed that patients with rare variants affecting the CTLA-4 pathway were more likely to respond to abatacept than those without the variants.
bit.ly
November 21, 2025 at 6:09 PM
Investigators have found that baseline T-cell activation patterns may predict which patients with immunoglobulin G4-related disease (#IgG4RD) are more likely to respond to #Abatacept, according to a letter to the editor in the European Journal of Internal Medicine.
Read more: https://bit.ly/3Me1kzY
Read more: https://bit.ly/3Me1kzY
Gastrointestinal manifestations of immunoglobulin G4-related disease (#IgG4RD) have diverse pathological and endoscopic features, according to a study published in the Journal of Gastroenterology.
Learn more: https://bit.ly/48df2M0
#RareDisease #Gastroenterology #ImmunoglobulinG4RelatedDisease
Learn more: https://bit.ly/48df2M0
#RareDisease #Gastroenterology #ImmunoglobulinG4RelatedDisease
IgG4-RD Gastrointestinal Manifestations Have Diverse Pathological, Endoscopic Features
Twenty-four cases of IgG4-GID were identified; of these, 20 cases included IgG4-RD manifestations in organs other than those in the gastrointestinal system.
bit.ly
November 13, 2025 at 4:50 PM
Gastrointestinal manifestations of immunoglobulin G4-related disease (#IgG4RD) have diverse pathological and endoscopic features, according to a study published in the Journal of Gastroenterology.
Learn more: https://bit.ly/48df2M0
#RareDisease #Gastroenterology #ImmunoglobulinG4RelatedDisease
Learn more: https://bit.ly/48df2M0
#RareDisease #Gastroenterology #ImmunoglobulinG4RelatedDisease
Stay current in clinical practice. This #CME activity helps you review key aspects of IgG4-related disease, from diagnosis to treatment.
Earn credit while testing your expertise.
Begin here ▶️ ms.spr.ly/63320smZfe
#IgG4RD
Earn credit while testing your expertise.
Begin here ▶️ ms.spr.ly/63320smZfe
#IgG4RD
November 7, 2025 at 2:00 PM
Stay current in clinical practice. This #CME activity helps you review key aspects of IgG4-related disease, from diagnosis to treatment.
Earn credit while testing your expertise.
Begin here ▶️ ms.spr.ly/63320smZfe
#IgG4RD
Earn credit while testing your expertise.
Begin here ▶️ ms.spr.ly/63320smZfe
#IgG4RD
#ACR25: Katharine Provencher, director of advocacy for the IgG4ward, which represents people like her husband, Andy, who has #IgG4RD. Provencher spoke Oct. 26 at the 2025 ACR Convergence
Image & quote taken by Senior Correspondent Larry Luxner
#RareDisease #RheumSky #MedSky
Image & quote taken by Senior Correspondent Larry Luxner
#RareDisease #RheumSky #MedSky
October 27, 2025 at 1:55 PM
#ACR25: Katharine Provencher, director of advocacy for the IgG4ward, which represents people like her husband, Andy, who has #IgG4RD. Provencher spoke Oct. 26 at the 2025 ACR Convergence
Image & quote taken by Senior Correspondent Larry Luxner
#RareDisease #RheumSky #MedSky
Image & quote taken by Senior Correspondent Larry Luxner
#RareDisease #RheumSky #MedSky
#ACR25: Alireza Meysami, MD, a rheumatologist and expert in IgG4-RD, speaking Oct. 26 at the 2025 ACR Convergence in Chicago.
Image and quote taken by Senior Correspondent, Larry Luxner
#RareDisease #Rheumatology #RheumSky #IgG4RD #MedSky
Image and quote taken by Senior Correspondent, Larry Luxner
#RareDisease #Rheumatology #RheumSky #IgG4RD #MedSky
October 26, 2025 at 7:00 PM
#ACR25: Alireza Meysami, MD, a rheumatologist and expert in IgG4-RD, speaking Oct. 26 at the 2025 ACR Convergence in Chicago.
Image and quote taken by Senior Correspondent, Larry Luxner
#RareDisease #Rheumatology #RheumSky #IgG4RD #MedSky
Image and quote taken by Senior Correspondent, Larry Luxner
#RareDisease #Rheumatology #RheumSky #IgG4RD #MedSky
FYI: LucidQuest Views >>> Rare Diseases Weekly News – August 21st 2025 #News #rarediseases #IgG4RD #OCD #GPP Comment below!
Rare Diseases Weekly News – August 21st 2025
🧬 This Week in Rare Diseases: FDA Approvals, Global Partnerships, Breakthrough Therapies, and More This week’s Rare Diseases roundup brings […]
The post Rare Diseases Weekly News – August 21st 2025 appeared first on LucidQuest Ventures.
dlvr.it
August 29, 2025 at 8:53 AM
FYI: LucidQuest Views >>> Rare Diseases Weekly News – August 21st 2025 #News #rarediseases #IgG4RD #OCD #GPP Comment below!
ICYMI: LucidQuest Views >>> Rare Diseases Weekly News – August 21st 2025 #News #rarediseases #IgG4RD #OCD #GPP Comment below!
Rare Diseases Weekly News – August 21st 2025
🧬 This Week in Rare Diseases: FDA Approvals, Global Partnerships, Breakthrough Therapies, and More This week’s Rare Diseases roundup brings […]
The post Rare Diseases Weekly News – August 21st 2025 appeared first on LucidQuest Ventures.
dlvr.it
August 22, 2025 at 8:52 AM
ICYMI: LucidQuest Views >>> Rare Diseases Weekly News – August 21st 2025 #News #rarediseases #IgG4RD #OCD #GPP Comment below!
LucidQuest Views >>> Rare Diseases Weekly News – August 21st 2025 #News #rarediseases #IgG4RD #OCD #GPP Comment below!
Rare Diseases Weekly News – August 21st 2025
🧬 This Week in Rare Diseases: FDA Approvals, Global Partnerships, Breakthrough Therapies, and More This week’s Rare Diseases roundup brings […]
The post Rare Diseases Weekly News – August 21st 2025 appeared first on LucidQuest Ventures.
dlvr.it
August 21, 2025 at 8:51 AM
LucidQuest Views >>> Rare Diseases Weekly News – August 21st 2025 #News #rarediseases #IgG4RD #OCD #GPP Comment below!
🧬 Publication dans Nature Reviews Rheumatology sur l’ #IgG4RD, #MaladieRare inflammatoire et fibrosante.
Le Pr Schleinitz #APHM y présente les avancées scientifiques et thérapeutiques.
👉 https://fr.ap-hm.fr/site/maladiesrares/actu/nature-reviews-rheumatology-focus-sur-la-maladie-liee-a-l-igg4
Le Pr Schleinitz #APHM y présente les avancées scientifiques et thérapeutiques.
👉 https://fr.ap-hm.fr/site/maladiesrares/actu/nature-reviews-rheumatology-focus-sur-la-maladie-liee-a-l-igg4
August 12, 2025 at 8:02 AM
🧬 Publication dans Nature Reviews Rheumatology sur l’ #IgG4RD, #MaladieRare inflammatoire et fibrosante.
Le Pr Schleinitz #APHM y présente les avancées scientifiques et thérapeutiques.
👉 https://fr.ap-hm.fr/site/maladiesrares/actu/nature-reviews-rheumatology-focus-sur-la-maladie-liee-a-l-igg4
Le Pr Schleinitz #APHM y présente les avancées scientifiques et thérapeutiques.
👉 https://fr.ap-hm.fr/site/maladiesrares/actu/nature-reviews-rheumatology-focus-sur-la-maladie-liee-a-l-igg4
Thanks to IgG4ward!’s dedication, Sam is now featured in their newsletter, website, and community gatherings, providing practical support at your fingertips. Learn more about this great partnership: steroidsandme.com/article/sam-...
#Partners #PatientAdvocacy #PatientSupport #IgG4RD
#Partners #PatientAdvocacy #PatientSupport #IgG4RD
July 9, 2025 at 7:39 PM
Thanks to IgG4ward!’s dedication, Sam is now featured in their newsletter, website, and community gatherings, providing practical support at your fingertips. Learn more about this great partnership: steroidsandme.com/article/sam-...
#Partners #PatientAdvocacy #PatientSupport #IgG4RD
#Partners #PatientAdvocacy #PatientSupport #IgG4RD
💡Rare Disease Spotlight: IgG4-RD
Learn more about this rare disease with our latest article checkrare.com/newly-approv...
#CheckRare #RareDisease #IgG4RD #RareAutoimmune #RareSkin
Learn more about this rare disease with our latest article checkrare.com/newly-approv...
#CheckRare #RareDisease #IgG4RD #RareAutoimmune #RareSkin
May 20, 2025 at 2:20 PM
💡Rare Disease Spotlight: IgG4-RD
Learn more about this rare disease with our latest article checkrare.com/newly-approv...
#CheckRare #RareDisease #IgG4RD #RareAutoimmune #RareSkin
Learn more about this rare disease with our latest article checkrare.com/newly-approv...
#CheckRare #RareDisease #IgG4RD #RareAutoimmune #RareSkin
🆕 Exciting time to dive into this, especially with the FDA’s recent approval of the first and only treatment, Inebilizumab😀❣️
#IgG4RD #Rheumsky
#IgG4RD #Rheumsky
April 9, 2025 at 9:24 AM
Finally also showing the results from the #MITIGATE study in #IgG4RD #igg4ward
#inebilizumab being approved by @fda.gov now for #IgG4RD !
#inebilizumab being approved by @fda.gov now for #IgG4RD !
Excellent talk by @maloehr.bsky.social on advances in autoimmune pancreatitis during Seoul IPBM 2025!
@myueg.bsky.social
@myueg.bsky.social
April 5, 2025 at 3:17 AM